Biotech Values

[DewDiligence]

ENTA’s CEO, Jay Luly, exercised and held the resulting shares on ~$530K of stock today:

http://www.sec.gov/Archives/edgar/data/1177648/000090866216000497/xslF345X03/edgar.xml

The options in question did not expire until 2021.

The last time Luly did an exercise-and-hold maneuver was in Oct 2015—right after the big drop in the share price due to the V-Pak label change (#msg-117951247).

Moreover, ENTA’s CSO executed exercise-and-hold transactions on $4M worth of stock in Jan 2016 (#msg-119968598).

Please see the thread culminating in #msg-109711695 for related info.